Tourmaline Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tourmaline Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • Tourmaline Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.79M, a 330% increase year-over-year.
  • Tourmaline Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $8.14M.
  • Tourmaline Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.77M, a 2858% increase from 2022.
  • Tourmaline Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $195K, a 94.8% decline from 2021.
  • Tourmaline Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.78M, a 270% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.14M $1.79M +$1.37M +330% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.76M $1.39M +$995K +253% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $5.77M $2.06M +$9.95M Oct 20, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $2.9M -$141K -4.64% Oct 19, 2023 10-Q 2024-08-08
Q3 2023 -$4.18M $1.25M -$1.79M -59% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$4.04M $416K -$2.43M -85.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.61M $393K -$1.8M -82.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $195K -$7.89M -$8.88M -894% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $9.08M $3.04M +$1.99M +189% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $7.09M $2.85M +$1.95M +218% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $5.14M $2.2M +$1.36M +163% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $3.78M $993K +$401K +67.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.38M $1.05M +$867K +464% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.51M $896K +$776K +647% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.73M $835K +$712K +579% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.02M $592K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $187K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $120K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $123K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.